Market Research Logo

US Market Report for Computed Tomography Imaging 2016 - MedCore

US Market Report for Computed Tomography Imaging 2016 - MedCore

Throughout the forecast however, the market lead will gradually shift towards the 64 slice scanner segment, due to their recognition as the industry standard. The 64 slice scanner segment will also be the only segment of the overall CT scanner market to exhibit any notable market growth. Lower slice segments in contrast, will remain stagnant as healthcare facilities slowly shift towards higher slice systems. The U.S. market for CT scanners includes 16/20 slice, 32/40 slice, 64 slice and ultra premium scanners, which take over 64 slices. The CT market has been decreasing since the implementation of the deficit reduction act (DRA) and furthermore with the recent introduction of XR-29, which reduced reimbursement for many CT scans.


LIST OF FIGURES
LIST OF CHARTS
EXECUTIVE SUMMARY
U.S. MEDICAL IMAGING DEVICE MARKET OVERVIEW
COMPETITIVE ANALYSIS
MARKET TRENDS
MARKET DEVELOPMENTS
PROCEDURE CODES INVESTIGATED
PROCEDURES INCLUDED
MARKETS INCLUDED
KEY REPORT UPDATES
VERSION HISTORY
RESEARCH METHODOLOGY
1.1 RESEARCH SCOPE
1.2 IDATA’S 9-STEP METHODOLOGY
Step 1: Project Initiation & Team Selection
Step 2: Prepare Data Systems and Perform Secondary Research
Step 3: Preparation for Interviews & Questionnaire Design
Step 4: Performing Primary Research
Step 5: Research Analysis: Establishing Baseline Estimates
Step 6: Market Forecast and Analysis
Step 7: Identify Strategic Opportunities
Step 8: Final Review and Market Release
Step 9: Customer Feedback and Market Monitoring
PRODUCT ASSESSMENT
2.1 PRODUCT PORTFOLIOS
2.1.1 Computed Tomography Imaging
2.2 REGULATORY ISSUES AND RECALLS
2.2.1 CT Devices
2.2.2 PET/CT Devices
2.2.3 SPECT Devices
2.2.4 SPECT/CT Devices
2.3 CLINICAL TRIALS
2.3.1 Bayer
2.3.2 Bracco
2.3.3 Carestream Health
2.3.4 Fujifilm
2.3.5 GE Healthcare
2.3.6 Guerbet
2.3.7 Hologic
2.3.8 Lantheus Medical Imaging
2.3.9 Philips Healthcare
2.3.10 Siemens Healthcare
2.3.11 Toshiba Medical Systems
COMPUTED TOMOGRAPHY IMAGING MARKET
3.1 MARKET OVERVIEW
3.2 MARKET ANALYSIS AND FORECAST
3.2.1 16/20 Slice Market
3.2.2 32/40 Slice Market
3.2.3 64 Slice Market
3.2.4 Ultra Premium Market
3.3 DRIVERS AND LIMITERS
3.3.1 Market Drivers
3.3.2 Market Limiters
3.4 COMPETITIVE MARKET SHARE ANALYSIS
ABBREVIATIONS
APPENDIX: COMPANY PRESS RELEASES
List of Charts
Chart 1 1: Medical Imaging Device Market by Segment, U.S., 2012 – 2022
Chart 1 2: Medical Imaging Device Market Overview, U.S., 2012 & 2022
Chart 3 1: Computed Tomography Imaging Market by Segment, U.S., 2012 – 2022
Chart 3 2: Computed Tomography Imaging Market Breakdown, U.S., 2015
Chart 3 3: Computed Tomography Imaging Market Breakdown, U.S., 2022
Chart 3 4: 16/20 Slice Market, U.S., 2012 – 2022
Chart 3 5: 32/40 Slice Market, U.S., 2012 – 2022
Chart 3 6: 64 Slice Market, U.S., 2012 – 2022
Chart 3 7: Ultra Premium Market, U.S., 2012 – 2022
Chart 3 8: Leading Competitors, Computed Tomography Imaging Market, U.S., 2015
List of Figures
Figure 1 1: Medical Imaging Device Competitor Market Share Ranking by Segment, U.S., 2015 (1 of 2)
Figure 1 2: Medical Imaging Device Competitor Market Share Ranking by Segment, U.S., 2015 (2 of 2)
Figure 1 3: Companies Researched in this Report, U.S., 2015 (1 of 2)
Figure 1 4: Companies Researched in this Report, U.S., 2015 (2 of 2)
Figure 1 5: Factors Impacting the Medical Imaging Device Market by Segment, U.S. (1 of 2)
Figure 1 6: Factors Impacting the Medical Imaging Device Market by Segment, U.S. (2 of 2)
Figure 1 7: Recent Events in the Medical Imaging Device Market, U.S., 2012 – 2015
Figure 1 8: Procedure Codes Investigated, U.S., 2015 (1 of 3)
Figure 1 9: Procedure Codes Investigated, U.S., 2015 (2 of 3)
Figure 1 10: Procedure Codes Investigated, U.S., 2015 (3 of 3)
Figure 1 11: Medical Imaging Procedures Covered, U.S., 2015 (1 of 4)
Figure 1 12: Medical Imaging Device Markets Covered, U.S., 2015 (1 of 3)
Figure 1 13: Medical Imaging Device Markets Covered, U.S., 2015 (2 of 3)
Figure 1 14: Medical Imaging Device Markets Covered, U.S., 2015 (3 of 3)
Figure 1 15: Key Report Updates
Figure 1 16: Version History
Figure 2 1: CT Devices by Company (1 of 2)
Figure 2 2: CT Devices by Company (2 of 2)
Figure 2 3: Class 2 Device Recall SOMATOM Sensation & SOMATOM Emotion series
Figure 2 4: Class 2 Device Recall GE PET/CT System
Figure 2 5: Class 2 Device Recall e.cam Dual Signature; Gamma Camera
Figure 2 6: Class 2 Device Recall Philips Healthcare
Figure 2 7: Class 2 Device Recall Philips Healthcare
Figure 2 8: Class 2 Device Recall GE Revolution CT System
Figure 2 9: Class 2 Device Recall Brilliance 64 CT System
Figure 2 10: Class 2 Device Recall Brillance, Big Bore CT
Figure 2 11: Class 2 Device Recall Brilliance Big Bore & Ingenuity Computed Tomography Xray systems
Figure 2 12: Class 2 Device Recall Aquilion CT TSX Systems
Figure 2 13: Class 2 Device Recall Siemens SOMATOM Force
Figure 2 14: Class 2 Device Recall SOMATOM Definition Edge
Figure 2 15: Class 2 Device Recall SOMATOM Definition Flash
Figure 2 16: Class 2 Device Recall SOMATOM Definition AS
Figure 2 17: Class 2 Device Recall Lightspeed 16 CT
Figure 2 18: Class 2 Device Recall Computed Tomography Xray Systems Ingenuity CT & Brilliance iCT
Figure 2 19: Class 2 Device Recall Head Holder shipped with Ingenuity Computed Tomography Xray Systems
Figure 2 20: Class 2 Device Recall SOMATOM Emotion 16 & 6
Figure 2 21: Class 2 Device Recall Ingenuity Core 128 & Ingenuity CT series
Figure 2 22: Class 2 Device Recall Brilliance CT series
Figure 2 23: Class 2 Device Recall Diamond Select Brilliance CT 16
Figure 2 24: Class 2 Device Recall iCT SP
Figure 2 25: Class 2 Device Recall MX 16 Slice & MX 16 Slice Phase II
Figure 2 26: Class 2 Device Recall Brilliance iCT
Figure 2 27: Class 2 Device Recall Ingenuity CT
Figure 2 28: Class 2 Device Recall Brilliance CT series
Figure 2 29: Class 2 Device Recall MX8000 Dualv. EXP
Figure 2 30: Class 2 Device Recall SOMATOM series
Figure 2 31: Class 2 Device Recall Several Philips Computed Tomography Systems
Figure 2 32: Class 2 Device Recall SIEMENS SOMATOM Force
Figure 2 33: Class 2 Device Recall GE Revolution CT computed tomography xray systems
Figure 2 34: Class 2 Device Recall Various Brilliance and Ingenuity systems
Figure 2 35: Class 2 Device Recall Revolution CT Scanner
Figure 2 36: Class 2 Device Recall SOMATOM Force
Figure 2 37: Class 2 Device Recall Philips Healthcare
Figure 2 38: Class 2 Device Recall Philips Healthcare
Figure 2 39: Class 2 Device Recall Aquilion versions
Figure 2 40: Class 2 Device Recall Ingenuity
Figure 2 41: Class 2 Device Recall Brillance CT System
Figure 2 42: Class 2 Device Recall Brilliance CT Big Bore
Figure 2 43: Class 2 Device Recall Brilliance 64 and Ingenuity CT
Figure 2 44: Class 2 Device Recall Philips Brilliance CT Big Bore Oncology and Philips Brilliance CT Big Bore Radiology
Figure 2 45: Class 2 Device Recall Siemens
Figure 2 46: Class 2 Device Recall Brilliance CT series
Figure 2 47: Class 2 Device Recall Brilliance CT
Figure 2 48: Class 2 Device Recall GE Healthcare Optima CT580/Discovery CT590RT scanners
Figure 2 49: Class 2 Device Recall CT system
Figure 2 50: Class 2 Device Recall TSXIOIA: Aquilion 32/64 ONE; System, XRay, Tomography, Computed
Figure 2 51: Class 2 Device Recall Siemens SOMATOM
Figure 2 52: Class 2 Device Recall Philips Brilliance CT system
Figure 2 53: Class 2 Device Recall GE Optima CT520 and Optima CT540
Figure 2 54: Class 2 Device Recall Brilliance iCT and Brilliance iCT SP
Figure 2 55: Class 2 Device Recall Brilliance iCT and iCT SP
Figure 2 56: Class 2 Device Recall Brilliance CT Big Bore Oncology & Brilliance CT Big Bore Radiology
Figure 2 57: Class 2 Device Recall Brilliance iCT Computed Tomography XRay System
Figure 2 58: Class 2 Device Recall Philips
Figure 2 59: Class 2 Device Recall GE, Optima CT660
Figure 2 60: Class 2 Device Recall MX 16Slice CT Scanner System
Figure 2 61: Class 2 Device Recall Brilliance CT
Figure 2 62: Class 2 Device Recall GE LightSpeed CT750 HD
Figure 2 63: Class 2 Device Recall Brilliance CT 64, Ingenuity Core, and Ingenuity Core128 scanner
Figure 2 64: Class 2 Device Recall The Brilliance 64, Ingenuity CT, Ingenuity Core, and Ingenuity Core128 scanners
Figure 2 65: Class 2 Device Recall Brilliance CT
Figure 2 66: Class 2 Device Recall NeuViz 16 MultiSlice CT Scanner System
Figure 2 67: Class 2 Device Recall NeuViz Dual series CT Scanner System
Figure 2 68: Class 2 Device Recall Philips Healthcare Computed Tomography XRay System
Figure 2 69: Class 2 Device Recall TSX30IC: AQUlLlON ONE; System, XRay, Tomography, Computed.
Figure 2 70: Class 2 Device Recall TSXIOI: AQUILION 32/64; System
Figure 2 71: Class 2 Device Recall Brilliance 64 and Ingenuity Computed Tomography XRay Systems
Figure 2 72: Class 2 Device Recall Brilliance
Figure 2 73: Class 2 Device Recall Philips Medical System
Figure 2 74: Class 2 Device Recall Philips MX 16Slice CT Scanner System
Figure 2 75: Class 2 Device Recall Brilliance Big Bore and Brilliance Big Bore Oncology CT XRay Scanners
Figure 2 76: Class 2 Device Recall Mx8000 IDT Whole Body Computed Tomography Xray system
Figure 2 77: Class 2 Device Recall Brilliance 64 and Ingenuity Computed Tomography (CT)
Figure 2 78: Class 2 Device Recall NeuViz
Figure 2 79: Class 2 Device Recall TSX301A/2 Aquilion One CT System
Figure 2 80: Class 2 Device Recall Brilliance 6, Brilliance 16, MX8000 Dual v. Exp, GEMINI Dual
Figure 2 81: Class 3 Device Recall Brilliance 16 Slice (Air)
Figure 2 82: Class 2 Device Recall MX 16slice
Figure 2 83: Class 2 Device Recall Aquilion One CT System, TSX301A/2
Figure 2 84: Class 2 Device Recall Scanner, Computed Tomography, Xray
Figure 2 85: Class 2 Device Recall Brilliance 6, 10, 16, 40, 64 and CT Big Bore
Figure 2 86: Class 2 Device Recall The Brilliance 64 and Ingenuity CT Computed Tomography Scanners
Figure 2 87: Class 2 Device Recall NeuViz 16 MultiSlice CT Scanner System
Figure 2 88: Class 2 Device Recall Brilliance CT
Figure 2 89: Class 2 Device Recall The Brilliance iCT and iCT SP
Figure 2 90: Class 2 Device Recall Brilliance iCT and iCT SP
Figure 2 91: Class 2 Device Recall Brilliance Computed Tomography XRay Scanning Systems
Figure 2 92: Class 2 Device Recall Extended Brilliance Workstation Computed Tomography XRay Systems
Figure 2 93: Class 2 Device Recall Brilliance Big Bore Computed Tomography XRay Systems
Figure 2 94: Class 2 Device Recall Brilliance 64 and Ingenuity CT Computed Tomography XRay Systems
Figure 2 95: Class 2 Device Recall Brilliance 64 and Ingenuity CT
Figure 2 96: Class 2 Device Recall InGenuity CT System
Figure 2 97: Class 2 Device Recall TSX301 A & B: AQUILION ONE
Figure 2 98: Class 2 Device Recall Brilliance Big Bore
Figure 2 99: Class 2 Device Recall Brilliance 64, Brilliance Big Bore, Brilliance iCT, Brilliance iCT SP, Ingenuity CT
Figure 2 100: Class 2 Device Recall Ingenuity CT system
Figure 2 101: Class 2 Device Recall Brilliance 64 CT system
Figure 2 102: Class 2 Device Recall Brilliance Big Bore CT system
Figure 2 103: Class 2 Device Recall Ingenuity CT System
Figure 2 104: Class 2 Device Recall GE PET/CT System
Figure 2 105: Class 2 Device Recall Gemini system
Figure 2 106: Class 2 Device Recall Toshiba Celesteion PCA9000A/2 PET/CT System
Figure 2 107: Class 2 Device Recall GEMINI TF/LXL/GXL CT/PET Systems
Figure 2 108: Class 2 Device Recall Gemini 16 PET/CT System
Figure 2 109: Class 2 Device Recall TruFlight Select PET/CT 16
Figure 2 110: Class 2 Device Recall GEMINI TF PET/CT 64 Slice
Figure 2 111: Class 2 Device Recall GEMINI TF PET/CT 16 Slice
Figure 2 112: Class 2 Device Recall CT LightSpeed 16 and Discovery ST Pet/CT DST
Figure 2 113: Class 2 Device Recall Gemini TF 16 PET/CT; Gemini RF 64 PET/CT; Gemini TF Big Bore
Figure 2 114: Class 2 Device Recall GEMINI LXL GEMINI TF PET/CT16 GEMINI TF PET/CT 64
Figure 2 115: Class 2 Device Recall Ingenuity TF PET/CT
Figure 2 116: Class 2 Device Recall GE Healthcare, PET VCAR
Figure 2 117: Class 2 Device Recall GE, VCT
Figure 2 118: Class 2 Device Recall Ingenuity TF PET/CT
Figure 2 119: Class 2 Device Recall Ingenuity TF PET/CT
Figure 2 120: Class 2 Device Recall Positron Emission Tomography (PET) and Xray Computed Tomography
Figure 2 121: Class 2 Device Recall TruFlight Select PET/CT Scanning System
Figure 2 122: Class 2 Device Recall Philips Medical Systems GEMINI
Figure 2 123: Class 2 Device Recall Siemens Medical Imaging
Figure 2 124: Class 2 Device Recall BrightView XCT & BrightView XCT
Figure 2 125: Class 2 Device Recall Siemens Medical Solutions USA
Figure 2 126: Class 2 Device Recall Siemens Medical Solutions USA
Figure 2 127: Class 2 Device Recall Siemens Medical Imaging
Figure 2 128: Class 2 Device Recall BrightView SPECT
Figure 2 129: Class 2 Device Recall Siemens Symbia E
Figure 2 130: Class 2 Device Recall BrightView XCT System Tomography Computed Emission
Figure 2 131: Class 2 Device Recall BrightView XCT BrightView X
Figure 2 132: Class 2 Device Recall Nuclear Gamma Cameras
Figure 2 133: Class 2 Device Recall BrightView XCT
Figure 2 134: Class 2 Device Recall SKYLight Imaging Systems
Figure 2 135: Class 2 Device Recall Symbia T Series
Figure 2 136: Perfusion CT as a Predictor for Response to Antiangiogenic Therapy
Figure 2 137: A Multicenter Study of Iomeron®-400
Figure 2 138: Retrospective Study of MRI in Pediatric Patients
Figure 2 139: A Pilot Trial Using BR55 Ultrasound Contrast Agent
Figure 2 140: Crossover Comparison of MultiHance and Dotarem (BENEFIT)
Figure 2 141: Multidetector Computed Tomography (MDCT) Tailored Protocol
Figure 2 142: Reproducibility and Repeatability of Multifunctional MRI Biomarkers of the Body
Figure 2 143: Reproducibility and Repeatability of Multifunctional MRI Biomarkers of the Body
Figure 2 144: CARESTREAM Vue PACS v12.1.5 CT Perfusion Clinical Protocol (CTP)
Figure 2 145: Clinical Evaluation of CARESTREAM Dual Energy and Digital Tomosynthesis
Figure 2 146: Clinical Evaluation of the Carestream PRO 3543 and PRO 3543C Digital Detectors
Figure 2 147: Clinical Evaluation of DRX Plus 3543 and DRX Plus 3543C Digital Detectors
Figure 2 148: Carestream Digital Radiography Long Length Imaging Software Data Collection Protocol (LLI-MSE)
Figure 2 149: A Multi-Reader Multi-Case Pivotal Trial
Figure 2 150: Pilot Mammography Reader Study
Figure 2 151: Acquisition of Breast Mammography Images
Figure 2 152: Study Comparing Flexible Spectral-Imaging Color Enhancement (FICE) With Olympus Narrow Band Imaging (NBI)
Figure 2 153: Pilot 3D Mammography Reader Study to Assess Breast Cancer Detection
Figure 2 154: Pilot Study Comparing Diagnostic Imaging Versus Tomosynthesis in Detection of Hip, Wrist or Tibia Injury (TOMO)
Figure 2 155: Collection of FUJIFILM's 3Dimensional Mammograms (3DM)
Figure 2 156: International Study to Determine if AdreView Heart Function Scan Can be Used to Identify Patients
Figure 2 157: Advanced MRI Applications for Mild Traumatic Brain Injury-Phase 2 (mTBI-phase2)
Figure 2 158: Assessment of Diagnostic Accuracy and Performance of Digital Breast Tomosynthesis
Figure 2 159: Non-invasive Quantification of Liver Iron With MRI
Figure 2 160: Assessment of Diagnostic Accuracy and Performance of Digital Breast Tomosynthesis
Figure 2 161: Assessment of Diagnostic Accuracy and Performance of Digital Breast Tomosynthesis
Figure 2 162: Development of a MR Scanner Capable of Being Sited in a Neonatal Intensive Care Unit (Firefly)
Figure 2 163: Phase 4 Study to Demonstrate Prognostic Usefulness of AdreView™ Scintigraphy
Figure 2 164: Clinical Evaluation of an Integrated PET/MRI System (PET/MR_ZURICH)
Figure 2 165: Automated Breast Ultrasound and Digital Breast Tomosynthesis Screening
Figure 2 166: Development of an Integrated PET/MR System, Accessories and Components
Figure 2 167: Comparison of 18F FDG PET/CT TO PET MRI (PET/MR US)
Figure 2 168: Compare Rates of Agreement Between Clinical Diagnosis and Visual Assessment of DaTscan™ Images
Figure 2 169: Open-label, Test-retest Study Assessing Reproducibility of Quantitative Measurements of Myocardial Uptake of AdreView
Figure 2 170: Clinical Evaluation for GE CT System
Figure 2 171: A Case Collection Study for Digital Breast Tomosynthesis (DBT)
Figure 2 172: Assess Safety, Bio-distribution, Radiation Dosimetry and Optimize the Imaging Protocol of GEH120714 (18F) Injection
Figure 2 173: Magnetic Resonance Imaging Using Innovative Pulse Sequences
Figure 2 174: MRI Scanning of People With MR Safe Orthopedic Implants That Are Made of Metal (MRI)
Figure 2 175: Contrast Ultrasound Detection of Sentinel Lymph Nodes
Figure 2 176: Feasibility of Short Breast MRI (SBMRI) for Screening Patients at High Risk for Breast Cancer
Figure 2 177: PET/CT for Staging Rectal Cancer Patients With and Without EMVI-MR
Figure 2 178: Contrast Enhanced Spectral Mammography (CESM) Study (CONTEND)
Figure 2 179: Assessment of Automated Breast Ultrasound
Figure 2 180: Feasibility of Ultrasound Microbubble Contrast-Enhanced (CEUS) Sentinel Lymph Node Imaging
Figure 2 181: How Beta-amyloid Imagining Influences Clinician Diagnosis and Management
Figure 2 182: Dual-Energy CT in Patients With Head and Neck Squamous Cell Carcinomas
Figure 2 183: Use of MIBG Scan Images in PVC Ablations (PVC-MIBG)
Figure 2 184: Comparison of Contrast-enhanced Spectral Mammography (CESM) to MRI
Figure 2 185: Fluoro-L-Thymidine Positron Emission Tomography (FLT PET) vs. Adv. Magnetic Resonance (MR) Techniques
Figure 2 186: A Pilot, Exploratory, Non-Randomized Study of PET/CT With the Investigational Agent [18F] Fluciclatide
Figure 2 187: 123I-mIBG SPECT Imaging
Figure 2 188: Preoperative Staging and Dose Escalated Radiotherapy of Prostate Carcinoma With PET and MRI (Flucipro)
Figure 2 189: FACBC PET and PEM as a Staging Tool and Indicator of Therapeutic Response in Breast Cancer Patients
Figure 2 190: The Assessment of Molecular Breast Imaging (MBI) in Distinguishing Benign From Malignant Breast Disease
Figure 2 191: Imaging Biomarkers of Delayed Sequelae in Trauma Brain Injury
Figure 2 192: Safety and Efficacy of Lipiodol® Ultra Fluid in Association With Surgical Glues During Vascular Embolization (In-Live)
Figure 2 193: P03277 Dose Finding Study in Central Nervous System (CNS) Magnetic Resonance Imaging (MRI)
Figure 2 194: Efficacy Evaluation of Dotarem®-Enhanced MRI Compared to Gadovist®/Gadavist®-Enhanced MRI
Figure 2 195: Evaluation of Inner Ear and Brain Structures With Contrast-enhanced MRI
Figure 2 196: Evaluation of Gadoterate in Patients With Decreased Kidney Function
Figure 2 197: Lipiodol as an Imaging Biomarker in Patients With Primary and Metastatic Liver Cancer
Figure 2 198: Hepatic Xenetix-CT Perfusion
Figure 2 199: Effects Contrast on Platelet Activity, Thrombosis and Fibrinolysis
Figure 2 200: Pancreatic Duct Evaluation in Autoimmune Pancreatitis: MR Pancreatography
Figure 2 201: Computed Tomography Versus Standard 2D Mammography Versus 3D Tomosynthesis
Figure 2 202: Open Label Study to Access Flurpiridaz F18 in PET MPI Verses SPECT MPI
Figure 2 203: Virtual Path Planning for Image-guided Needle Interventions
Figure 2 204: Applications of Dual-Energy Computed Tomography
Figure 2 205: X-ray Dose Reduction Study for Cardiac Angiography and Intervention
Figure 2 206: X-ray Dose Reduction Study for Endovascular Interventional Radiology
Figure 2 207: X-ray Dose Reduction in Electrophysiology
Figure 2 208: Multicenter Study of Magnetic Resonance-guided High Intensity Focused Ultrasound
Figure 2 209: MRI/TRUS Fusion Guided Prostate Biopsy- An Improved Way to Detect and Quantify Prostate Cancer
Figure 2 210: Sonalleve Fibroid Ablation Pivotal Clinical Trial for MR-HIFU of Uterine Fibroids (SOFIA)
Figure 2 211: Cardiovascular Magnetic Resonance-Guided Radiofrequency-Ablation for Atrial Flutter
Figure 2 212: Percutaneous Closure of Atrial Septal Defects in Children
Figure 2 213: Assessment of 3D Transperineal Ultrasound Imaging w/ Matrix Array Transducers in Prostate Radiotherapy
Figure 2 214: Radio Frequency Ablation for Atrial Flutter With Magnetic Resonance Guidance and Tracking
Figure 2 215: Chest Ultrasound of ER Patients With Cough or SOB
Figure 2 216: The Value of MultiSpectral 3 Tesla MRI in Active Surveillance of Prostate Cancer
Figure 2 217: Multi Modal Cardiac Imaging Prior Transcatheter Aortic Valve Implantation
Figure 2 218: MRI Guided High Intensity Focused Ultrasound (HIFU) and ThermoDox for Palliation of Painful Bone Metastases
Figure 2 219: Evaluation of Diagnostic Accuracy of Contrast Enhanced Dual Energy Mammography Imaging
Figure 2 220: Evaluation of an Innovative Medical Device Supporting Orthopedic Surgical Interventions (VIPS)
Figure 2 221: PET/MRI in Patients With Suspected Prostate Cancer
Figure 2 222: Perfusion CT as a Predictor for Response to Antiangiogenic Therapy
Figure 2 223: Verification of the Quantitative Accuracy of the PET/CT System Imaging Chain
Figure 2 224: General Investigative MRI Protocol
Figure 3 1: Computed Tomography Imaging Market by Segment, U.S., 2012 – 2022 (US$M)
Figure 3 2: 16/20 Slice Market, U.S., 2012 – 2022
Figure 3 3: 32/40 Slice Market, U.S., 2012 – 2022
Figure 3 4: 64 Slice Market, U.S., 2012 – 2022
Figure 3 5: Ultra Premium Market, U.S., 2012 – 2022
Figure 3 6: Drivers and Limiters, Computed Tomography Imaging Market, U.S., 2015
Figure 3 7: Leading Competitors, Computed Tomography Imaging Market, U.S., 2015
Figure 5 1: Press Release Summary

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report